| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.093 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.056 | 0.3 |